Pancreatic Cancer Research

ResearcherThe University of Texas at AustinActive in the last 2 years

William H. Matsui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3088-0964; OpenAlex author ID A5027419360; NIH RePORTER profile ID 6354151. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 6)
Trials
0
Grants
2
Labs led
2
Collaborators
40
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: none · 2014: 1 paper · 2015: 1 grant · 2016: none · 2017: 2 papers · 2018: none · 2019: 4 papers · 2020: none · 2021: 1 grant · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 13

  1. Collagen nanofiber alignment attenuates leader-follower energetic and metabolic differences during collective migration in pancreatic cancer. Co-author DOI 10.1016/j.actbio.2025.11.031↗
  2. Quiescent tumor cells shape the immunosuppressive microenvironment in pancreatic cancer. Last author DOI 10.1038/s41467-026-75883-z↗
  3. IQGAP1 Maintains Pancreatic Ductal Adenocarcinoma Clonogenic Growth and Metastasis. Last author DOI 10.1097/mpa.0000000000001198↗
  4. Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. Last author DOI 10.1097/mpa.0000000000001249↗
  5. Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture. Co-author DOI 10.1097/mpa.0000000000001390↗
  6. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/1541-7786.mcr-18-0367↗
  7. Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol. Co-author DOI 10.1002/jcb.25668↗
  8. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma. Last author DOI 10.1371/journal.pone.0180181↗
  9. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Co-author DOI 10.1053/j.gastro.2013.09.050↗
  10. Biological and clinical relevance of stem cells in pancreatic adenocarcinoma. First author DOI 10.1111/j.1440-1746.2011.07015.x↗
  11. Heterogeneity and targeting of pancreatic cancer stem cells. Last author DOI 10.1158/1078-0432.ccr-11-3112↗
  12. The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Co-author DOI 10.1158/1535-7163.mct-12-0017↗
  13. Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Co-author DOI 10.4161/cbt.12.7.16475↗

Grants 2

  1. TARGETING EXTRACELLULAR MATRIX-CANCER STEM CELL INTERACTIONS IN PANCREATIC CANCER R01CA193887↗
  2. Cellular diversity and clinical relevance of stem cells in pancreatic cancer R01CA150142↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bryan McClellan · 1 shared paper, 2026 · strength 0.43
  2. Kyaw Lwin Aung · 1 shared paper, 2026 · strength 0.43
  3. Zeshaan A. Rasheed · 8 shared papers, 2011–2019 · strength 0.42
  4. Anirban Maitra · 7 shared papers, 2011–2019 · strength 0.35
  5. Asma Begum · 4 shared papers, 2017–2019 · strength 0.35
  6. Sapun H. Parekh · 1 shared paper, 2026 · strength 0.32
  7. Madison Pickett · 1 shared paper, 2026 · strength 0.32
  8. Vesselin R. Penchev · 4 shared papers, 2012–2019 · strength 0.27
  9. Joey H. Li · 2 shared papers, 2019 · strength 0.21
  10. N.V. Rajeshkumar · 4 shared papers, 2011–2019 · strength 0.19
  11. Christopher Lee Wolfgang · 2 shared papers, 2017–2019 · strength 0.14
  12. Laura DeLong Wood · 2 shared papers, 2017–2019 · strength 0.13
  13. Feng Wang · 1 shared paper, 2017 · strength 0.10
  14. Farhad Parhami · 1 shared paper, 2017 · strength 0.10
  15. Michael Goggins · 1 shared paper, 2019 · strength 0.09
  16. Robert A. Anders · 1 shared paper, 2019 · strength 0.08
  17. Yoshihisa Matsushita · 1 shared paper, 2019 · strength 0.08
  18. Nicholas Jason Roberts · 1 shared paper, 2019 · strength 0.08
  19. James R. Eshleman · 1 shared paper, 2019 · strength 0.08
  20. Ralph H. Hruban · 1 shared paper, 2019 · strength 0.08
  21. Ana De Jesus‐Acosta · 1 shared paper, 2017 · strength 0.05
  22. Daniel A. Laheru · 1 shared paper, 2017 · strength 0.05
  23. Manuel M. Hidalgo · 2 shared papers, 2011–2012 · strength 0.05
  24. Ruben R. Plentz · 1 shared paper, 2014 · strength 0.04
  25. Hao Zhang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.